{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:06:37Z","timestamp":1790204797222,"version":"4.1.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The triglyceride-glucose-body mass index (TyG\u2013BMI) is a simple indicator of insulin resistance and is linked to an elevated risk of mortality. Nevertheless, limited research has explored the associations between the TyG\u2013BMI and all-cause and cardiovascular mortality in patients undergoing peritoneal dialysis (PD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients initiating PD treatment at the Tianjin First Central Hospital\u2019s Nephrology Department from July 2013 to February 2024 had triglycerides, fasting blood glucose, height, and weight measured at baseline and monthly during follow-up. TyG\u2013BMI was calculated, dividing PD patients into high, middle, or low TyG\u2013BMI groups using the tri-quantile method. Cox regression analysis assessed hazard ratios (HRs) for all-cause and cardiovascular mortality among these groups. A restricted cubic spline regression was used to explore the relationship between TyG\u2013BMI and the primary and secondary outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 865 patients were included. The mean TyG\u2013BMI value for the entire study population was 212.27\u202f\u00b1\u202f46.64. Patients in the high TyG\u2013BMI group had a higher proportion of patients whose primary kidney disease was diabetic nephropathy and the greatest proportion of patients with comorbid diabetes mellitus. During the follow-up, 266 (30.75%) deaths occurred, with CVD being the dominant cause in 110 (41.35%) patients. Univariate and multivariate Cox regression analyses showed that middle group patients had a significantly lower risk of all-cause mortality compared to other groups. For CVD mortality, high group patients had a significantly greater hazard ratio than middle group patients, while there was no significant difference between the low and middle groups. Restricted cubic spline regression revealed a U-shaped association between TyG\u2013BMI and all-cause mortality risk, as well as a J-shaped association with CVD mortality; inflection points were identified at 209.73 and 206.64, respectively. In the subgroup analysis, we found that higher TyG\u2013BMI values were associated with increased all-cause and cardiovascular mortality in men, and lower TyG\u2013BMI values were linked to elevated all-cause mortality in women.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The TyG\u2013BMI shows U-shaped and J-shaped relationships with all-cause and CVD mortality risk, respectively, in PD patients. Additionally, significant sex differences were observed in these associations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2025.1612402","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T04:14:53Z","timestamp":1755663293000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Correlation of the triglyceride-glucose-body mass index with all-cause and cardiovascular mortality in patients undergoing peritoneal dialysis: a retrospective cohort study"],"prefix":"10.3389","volume":"12","author":[{"given":"Jinping","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xichao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"101463","DOI":"10.1016\/j.lanwpc.2024.101463","article-title":"Prevalence of chronic kidney disease among Chinese adults with diabetes: a nationwide population-based crosssectional study","volume":"55","author":"Jia","year":"2025","journal-title":"Lancet Reg Health"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e00023","DOI":"10.1097\/IMNA-D-22-00023","article-title":"Clinical characteristics and Chinese medicine therapy of chronic kidney disease combined with cardiovascular disease","volume":"10","author":"Zhu","year":"2023","journal-title":"Integr Med Nephrol Androl"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/s41401-025-01476-z","article-title":"Cardiorenal syndrome: clinical diagnosis, molecular mechanisms and therapeutic strategies","volume":"46","author":"Zhao","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1338044","DOI":"10.3389\/fphar.2024.1338044","article-title":"Efficacy and safety of nonsteroidal mineralocorticoid receptor antagonists for renal and cardiovascular outcomes in patients with chronic kidney disease: a meta-analysis of randomized clinical trials","volume":"15","author":"Chen","year":"2024","journal-title":"Front Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.5527\/wjn.v12.i5.182","article-title":"Heterogeneity in cardiorenal protection by sodium glucose cotransporter 2 inhibitors in heart failure across the ejection fraction strata: systematic review and meta-analysis","volume":"12","author":"Taheri","year":"2023","journal-title":"World J Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41581-022-00623-7","article-title":"Epidemiology of peritoneal dialysis outcomes","volume":"18","author":"Bello","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2215\/CJN.07920910","article-title":"Peritoneal dialysis first: rationale","volume":"6","author":"Chaudhary","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000441580","article-title":"Sustainability of the peritoneal dialysis-first policy in Hong Kong","volume":"40","author":"Choy","year":"2015","journal-title":"Blood Purif"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3747\/pdi.2017.00182","article-title":"Outcomes and challenges of a PD-first program, a south-African perspective","volume":"38","author":"Davidson","year":"2018","journal-title":"Perit Dial Int"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1053\/j.ajkd.2018.12.033","article-title":"International variations in peritoneal Dialysis utilization and implications for practice","volume":"74","author":"Briggs","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ndt\/16.suppl_5.61","article-title":"Integrated end-stage renal disease care: the role of peritoneal dialysis","volume":"16","author":"Blake","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12933-023-01937-x","article-title":"The cardio-renal-metabolic connection: a review of the evidence","volume":"22","author":"Marassi","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/ndt\/15.1.65","article-title":"Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis","volume":"15","author":"Kobayashi","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.2215\/CJN.03170315","article-title":"Insulin resistance in nondiabetic peritoneal Dialysis patients: associations with body composition, peritoneal transport, and peritoneal glucose absorption","volume":"10","author":"Bernardo","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrneph.2010.68","article-title":"Cardiovascular risk in the peritoneal dialysis patient","volume":"6","author":"Krediet","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12020-023-03574-6","article-title":"Correlation between alternative insulin resistance indexes and diabetic kidney disease: a retrospective study","volume":"84","author":"Mu","year":"2024","journal-title":"Endocrine"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"14791641231173617","DOI":"10.1177\/14791641231173617","article-title":"TyG-BMI and hypertension in normoglycemia subjects in Japan: a cross-sectional study","volume":"20","author":"Huang","year":"2023","journal-title":"Diab Vasc Dis Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12933-023-01983-5","article-title":"Changes in the triglyceride glucose-body mass index estimate the risk of stroke in middle-aged and older Chinese adults: a nationwide prospective cohort study","volume":"22","author":"Huo","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1327903","DOI":"10.3389\/fendo.2024.1327903","article-title":"Correlation of TyG-BMI and TyG-WC with severity and short-term outcome in new-onset acute ischemic stroke","volume":"15","author":"Yu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12933-023-01794-8","article-title":"Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study","volume":"22","author":"Cheng","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12933-022-01541-5","article-title":"Triglyceride-glucose index variability and incident cardiovascular disease: a prospective cohort study","volume":"21","author":"Li","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","article-title":"The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018","volume":"23","author":"Dang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3390\/nu15030639","article-title":"Association between the triglyceride-glucose index and vitamin D status in type 2 diabetes mellitus","volume":"15","author":"Xiang","year":"2023","journal-title":"Nutrients"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/j.ekir.2023.08.021","article-title":"Triglyceride-glucose index and cardiovascular events in kidney transplant recipients","volume":"8","author":"Colladant","year":"2023","journal-title":"Kidney Int Rep"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1177\/1747493020984069","article-title":"Triglyceride-glucose index is associated with early neurological deterioration in single subcortical infarction: early prognosis in single subcortical infarctions","volume":"16","author":"Nam","year":"2021","journal-title":"Int J Stroke"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"M139","DOI":"10.1097\/00002480-199207000-00004","article-title":"Cross-sectional assessment of weekly urea and creatinine clearances in patients on continuous ambulatory peritoneal dialysis","volume":"38","author":"Nolph","year":"1992","journal-title":"ASAIO J"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.numecd.2015.05.006","article-title":"Higher serum triglyceride to high-density lipoprotein cholesterol ratio was associated with increased cardiovascular mortality in female patients on peritoneal dialysis","volume":"25","author":"Wu","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1106339","DOI":"10.3389\/fphar.2023.1106339","article-title":"Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation","volume":"14","author":"Lu","year":"2023","journal-title":"Front Pharmacol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1193754","DOI":"10.3389\/fmed.2023.1193754","article-title":"Construction and validation of a predictive model for the risk of peritoneal dialysis-associated peritonitis after peritoneal dialysis catheterization","volume":"10","author":"Dai","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/IMNA-D-24-00012","article-title":"A case of peritoneal dialysis-associated encapsulated peritoneal sclerosis treated with a combination of Chinese and Western medicine","volume":"11","author":"Wang","year":"2024","journal-title":"Integr Med Nephrol Androl"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1356478","DOI":"10.3389\/fmicb.2024.1356478","article-title":"Causal relationship between gut microbiota and chronic renal failure: a two-sample mendelian randomization study","volume":"15","author":"Liu","year":"2024","journal-title":"Front Microbiol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1458090","DOI":"10.3389\/fmicb.2024.1458090","article-title":"Fecal bile acid dysmetabolism and reduced ursodeoxycholic acid correlate with novel microbial signatures in feline chronic kidney disease","volume":"15","author":"Rowe","year":"2024","journal-title":"Front Microbiol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41401-023-01148-w","article-title":"Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1\/\u03b2-catenin pathway","volume":"45","author":"Miao","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1302352","DOI":"10.3389\/fmed.2023.1302352","article-title":"Specific gut microbiome and metabolome changes in patients with continuous ambulatory peritoneal dialysis and comparison between patients with different dialysis vintages","volume":"10","author":"Li","year":"2024","journal-title":"Front Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41392-024-01913-1","article-title":"Targeting Lactobacillus johnsonii to reverse chronic kidney disease","volume":"9","author":"Miao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e00017","DOI":"10.1097\/IMNA-D-23-00017","article-title":"Bibliometric analysis of the relationship between gut microbiota and chronic kidney disease from 2001\u20132022","volume":"11","author":"Tao","year":"2024","journal-title":"Integr Med Nephrol Androl"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41401-022-00947-x","article-title":"Integrative phosphatidylcholine metabolism through phospholipase a(2) in rats with chronic kidney disease","volume":"44","author":"Wang","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"101509","DOI":"10.1016\/j.gendis.2024.101509","article-title":"The role of lncRNAs in AKI and CKD: molecular mechanisms, biomarkers, and potential therapeutic targets","volume":"12","author":"Zheng","year":"2024","journal-title":"Genes Dis"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"420","DOI":"10.7150\/thno.89105","article-title":"Klotho-derived peptide 1 inhibits cellular senescence in the fibrotic kidney by restoring klotho expression via posttranscriptional regulation","volume":"14","author":"Zhang","year":"2024","journal-title":"Theranostics"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1238981","DOI":"10.3389\/fendo.2023.1238981","article-title":"LncRNA H19: a novel player in the regulation of diabetic kidney disease","volume":"14","author":"Wu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13098-018-0376-8","article-title":"Metabolic clustering of risk factors: evaluation of triglyceride-glucose index (TyG index) for evaluation of insulin resistance","volume":"10","author":"Khan","year":"2018","journal-title":"Diabetol Metab Syndr"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12933-023-02028-7","article-title":"The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease","volume":"22","author":"Xie","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/ki.2010.392","article-title":"Risk stratification for cardiac death in hemodialysis patients without obstructive coronary artery disease","volume":"79","author":"Nishimura","year":"2011","journal-title":"Kidney Int"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fendo.2017.00182","article-title":"Is there a role for bioactive lipids in the pathobiology of diabetes mellitus?","volume":"8","author":"Das","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13098-023-01153-3","article-title":"The triglyceride glucose index was U-shape associated with all-cause mortality in population with cardiovascular diseases","volume":"15","author":"Li","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3747\/pdi.2013.00055","article-title":"Body mass index and mortality risk in asian peritoneal dialysis patients in Hong Kong-impact of diabetes and cardiovascular disease status","volume":"34","author":"Kiran","year":"2014","journal-title":"Perit Dial Int"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/ndt\/gfw075","article-title":"Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis","volume":"32","author":"Ladhani","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3747\/pdi.2015.00052","article-title":"Association of Body Mass Index with Mortality in peritoneal Dialysis patients: a systematic review and Meta-analysis","volume":"36","author":"Ahmadi","year":"2016","journal-title":"Perit Dial Int"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13098-023-01117-7","article-title":"Sex differences in the nonlinear association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population","volume":"15","author":"Yu","year":"2023","journal-title":"Diabetol Metab Syndr"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1612402\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T04:14:54Z","timestamp":1755663294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1612402\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":51,"alternative-id":["10.3389\/fnut.2025.1612402"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1612402","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"article-number":"1612402"}}